131 related articles for article (PubMed ID: 10962312)
1. Long-term survival in a Swedish population-based cohort of men with prostate cancer.
Sandblom G; Dufmats M; Varenhorst E
Urology; 2000 Sep; 56(3):442-7. PubMed ID: 10962312
[TBL] [Abstract][Full Text] [Related]
2. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
Johansson JE; Holmberg L; Johansson S; Bergström R; Adami HO
JAMA; 1997 Feb; 277(6):467-71. PubMed ID: 9020270
[TBL] [Abstract][Full Text] [Related]
3. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
Lu-Yao GL; Albertsen PC; Moore DF; Lin Y; DiPaola RS; Yao SL
Eur Urol; 2015 Nov; 68(5):805-11. PubMed ID: 25800944
[TBL] [Abstract][Full Text] [Related]
4. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
[TBL] [Abstract][Full Text] [Related]
5. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors.
Helgesen F; Holmberg L; Johansson JE; Bergström R; Adami HO
J Natl Cancer Inst; 1996 Sep; 88(17):1216-21. PubMed ID: 8780631
[TBL] [Abstract][Full Text] [Related]
6. Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE
Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival among men with conservatively treated localized prostate cancer.
Albertsen PC; Fryback DG; Storer BE; Kolon TF; Fine J
JAMA; 1995 Aug 23-30; 274(8):626-31. PubMed ID: 7637143
[TBL] [Abstract][Full Text] [Related]
8. [The natural course of untreated, localized primary prostate carcinoma].
Johansson JE
Urologe A; 1996 Nov; 35(6):446-8. PubMed ID: 9064880
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
10. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
Scand J Urol Nephrol; 2005; 39(2):117-23. PubMed ID: 16019764
[TBL] [Abstract][Full Text] [Related]
11. The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades.
Klaff R; Rosell J; Varenhorst E; Sandblom G
Urology; 2016 May; 91():77-82. PubMed ID: 26879734
[TBL] [Abstract][Full Text] [Related]
12. 20-year outcomes following conservative management of clinically localized prostate cancer.
Albertsen PC; Hanley JA; Fine J
JAMA; 2005 May; 293(17):2095-101. PubMed ID: 15870412
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age.
Grönberg H; Damber L; Jonson H; Damber JE
Urology; 1997 Mar; 49(3):374-8. PubMed ID: 9123701
[TBL] [Abstract][Full Text] [Related]
15. Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study.
Thorstenson A; Garmo H; Adolfsson J; Bratt O
J Urol; 2017 Jan; 197(1):61-66. PubMed ID: 27328367
[TBL] [Abstract][Full Text] [Related]
16. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
17. Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
Aizer AA; Chen MH; Hattangadi J; D'Amico AV
BJU Int; 2014 Jan; 113(1):43-50. PubMed ID: 23473327
[TBL] [Abstract][Full Text] [Related]
18. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.
Albertsen PC; Hanley JA; Gleason DF; Barry MJ
JAMA; 1998 Sep; 280(11):975-80. PubMed ID: 9749479
[TBL] [Abstract][Full Text] [Related]
19. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
[TBL] [Abstract][Full Text] [Related]
20. [Delayed therapy of clinically localized prostatic carcinoma. Experiences of the Karolinska Hospital].
Adolfsson J
Urologe A; 1996 Nov; 35(6):454-5. PubMed ID: 9064882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
